StonvexLoading…
StonvexCore line items from AUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.00M | $3.00M | $2.00M | $1.00M |
Operating Income | $-244.00M | $-901.00M | $-663.00M | $-441.00M |
Net Income | $-223.00M | $-816.00M | $-610.00M | $-409.00M |
EPS (Diluted) | $-0.11 | $-0.44 | $-0.34 | $-0.23 |
Total Assets | $2.19B | $2.34B | $2.51B | $2.21B |
Total Liabilities | $221.00M | $203.00M | $219.00M | $223.00M |
Cash & Equivalents | $273.00M | $221.00M | $87.00M | $206.00M |
Free Cash Flow OCF − CapEx | $-184.00M | $-612.00M | $-458.00M | $-301.00M |
Shares Outstanding | 1.96B | 1.94B | 1.93B | 1.84B |